Technical Comparison
Recursion Pharmaceuticals, Inc. - Class A Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between RXRX and NVDA.
Primary Asset
RXR
Recursion Pharmaceuticals, Inc. - Class A Common Stock
Market Rank #1004267Live Price$3.05
Market Capitalization$1.6B
24h Change+1.33%
Circulating Supply525M RXRX
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$197.01
Market Capitalization$4.8T
24h Change+0.25%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | RXRX Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1004267 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $3.05 | $197.01 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $1.6B | $4.8T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock bigger than NVIDIA Corporation - Common Stock?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has a market cap of $1.6B, while NVIDIA Corporation - Common Stock sits at $4.8T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Recursion Pharmaceuticals, Inc. - Class A Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 RXRX is worth 0.02 NVDA.